<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Antithyroid Drugs</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->


      <h1>Antithyroid Drugs</h1>

  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div>
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
        <!-- READ SUMMARY CONTAINER -->
        
              <!-- Summary Overlay -->
              <div class="summary-overlay" id="summaryOverlay"></div>
        
        
              <div class="summary-card" id="summaryCard">
                
                <div class="summary-header">
                  <h3>Note Summary</h3>
                  <div class="icon-box">
                    <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                    <img src="../images/icons/summary.png" alt="Icon" class="icon">
                  </div>
                </div>
                <div class="summary-content">
                  <!-- Summary content goes here -->
                  <p><i>This content is not available yet.</i></p>
        
                  <span class="close-btn" id="closeBtn">close</span>
                </div>
              </div>
        
              <div class="summary-trigger" id="summaryTrigger">
                <p>Click here to read a summary</p>
            </div>
        <!-- END OF READ SUMMARY CONTAINER -->
        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Thyroid Physiology</a>
          </h2>
        </header>
        <div class='body'>
            <p>The <strong>thyroid gland</strong> produces three main hormones: <strong>tri-iodothyronine (T3)</strong> and <strong>thyroxine (T4-tetra-iodothyronine)</strong> and <strong>calcitonin</strong> (involved in the control of plasma calcium).</p>
            <ul>
                <li><strong>T3</strong> is more potent than <strong>T4</strong></li>
                <li>Liothyronine is the synthetic <strong>T3</strong> and levothyroxine is synthetic <strong>T4</strong></li>
            </ul>
            
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Synthesis and Fate of Thyroid Hormones</a>
          </h2>
        </header>
        <div class='body'>
            <p>Formation of thyroid hormone begins with:</p>
            <ol>
                <li>Active transport of <strong>iodide</strong> into the thyroid gland</li>
                <li>Oxidation of iodide to <strong>iodine</strong> (the active form of iodide), which is catalyzed by <strong>thyroperoxidase</strong> enzyme</li>
                <li>Activated iodine is incorporated into <strong>tyrosine residues</strong> that are bound to <strong>thyroglobulin</strong> (a large glycoprotein molecule), resulting in formation of <strong>monoiodotyrosine (MIT)</strong> and <strong>diiodotyrosine (DIT)</strong></li>
                <li>Coupling of iodinated tyrosine molecules takes place.
                    <ul>
                        <li>Coupling of one <strong>MIT</strong> with <strong>DIT</strong> produces <strong>T3</strong></li>
                        <li>Coupling of two <strong>DIT</strong> molecules produces <strong>T4</strong></li>
                    </ul>
                </li>
            </ol>

            <h4>Fate</h4>
            <p>Thyroid hormones are released from the thyroid gland by a proteolytic process. The amount of <strong>T4</strong> released is greater than the amount of <strong>T3</strong>. However, much of <strong>T4</strong> released undergoes conversion to <strong>T3</strong> by enzymes in peripheral tissues.</p>
            <ul>
                <li>About <strong>80%</strong> of <strong>T3</strong> found in plasma is due to conversion of <strong>T4</strong> to <strong>T3</strong></li>
                <li>In blood both <strong>T3</strong> and <strong>T4</strong> are extensively (<strong>99.9%</strong>) bound to plasma proteins (thyroxine binding globulin <strong>TBG</strong> and thyroxine binding prealbumin <strong>TBPA</strong>)</li>
            </ul>
            <p>Only free circulating thyroid hormones produce biological effects.</p>
            <p>Both <strong>T3</strong> and <strong>T4</strong> are metabolized in the liver, which is slow, so half-lives of these hormones are prolonged. Half-life of <strong>T3</strong> is <strong>1.5 days</strong> and half-life of <strong>T4</strong> is <strong>1 week</strong>.</p>
            
            <p><strong>TSH</strong> acts on the thyroid gland causing an increase in:</p>
            <ol>
                <li>Gland size</li>
                <li>Iodine uptake</li>
                <li>Synthesis and release of thyroid hormones</li>
            </ol>
            <p>The rising plasma levels of <strong>T3</strong> and <strong>T4</strong> lead to suppression of <strong>TSH</strong> release.</p>
            

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Hyperthyroidism (Thyrotoxicosis)</a>
          </h2>
        </header>
        <div class='body'>
            <ol>
                <li>Diffuse toxic goiter (Grave's disease)</li>
                <li>Toxic nodular goiter (adenoma)</li>
            </ol>
            <p>The symptoms are due to supra-physiological amounts of thyroid hormones leading to <strong>tachycardia, nervousness, tremor, diarrhea, increase in skin temperature and sweating, marked sensitivity to heat (BMR), fatigability, increased appetite with weight loss</strong>.</p>
            
            <h4>Aim of Treatment</h4>
            <p>To reduce excessive secretion of thyroid hormones by:</p>
            <ol>
                <li>Subtotal thyroidectomy or radioactive iodine (<strong>131I</strong>) to reduce the amount of functioning thyroid tissue</li>
                <li>Antithyroid drugs to decrease secretion of thyroid hormones</li>
                <li>Symptomatic treatment with <strong>beta-blockers</strong></li>
            </ol>
            
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Antithyroid Drugs</a>
          </h2>
        </header>
        <div class='body'>
            <section id='heading-4-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-1'>Thionamides (Thiourea Derivatives)</a>
                  </h3>
                </header>
                <div class='body'>
                    <p><strong>Carbimazole</strong>, <strong>Methimazole</strong>, & <strong>Propylthiouracil</strong></p>
                    <p><strong>Methimazole</strong> is the chief metabolite of <strong>carbimazole</strong>.</p>
                    
                    <h4>Mechanism of Action</h4>
                    <ol>
                        <li>
                            Block thyroid hormone synthesis by:
                            <ol type="a">
                                <li> Preventing oxidation of iodide, thus inhibiting incorporation of iodine into tyrosine</li>
                                <li> Preventing iodinated tyrosine from coupling</li>
                            </ol>
                            <p>Both these effects are due to inhibiting <strong>thyroperoxidase</strong> enzyme.</p>
                        </li>
                        <li>
                            <p><strong>Propylthiouracil</strong> also acts peripherally to suppress conversion of <strong>T4</strong> to <strong>T3</strong>.</p>
                            <p>Although <strong>propylthiouracil</strong> prevents thyroid hormone synthesis, it does not destroy existing stores of thyroid hormone, so once therapy begins, it may take <strong>1-2 weeks</strong> for existing stores to become depleted.</p>
                        </li>
                    </ol>
                    
                    <h4>Therapeutic Uses</h4>
                    <ol>
                        <li>Alone in <strong>Grave's disease</strong></li>
                        <li>As an adjunct to radiation therapy</li>
                        <li>In preparation for thyroid surgery</li>
                        <li><strong>Propylthiouracil</strong> for thyrotoxic crisis (by inhibiting hormone synthesis and preventing conversion of <strong>T4</strong> to <strong>T3</strong>).</li>
                    </ol>

                    <h4>Adverse Effects</h4>
                    <p>Adverse effects are relatively rare; however, severe adverse effects can occur:</p>
                    <ul>
                        <li><strong>Agranulocytosis</strong> is the most serious toxicity, usually occurring during the first 2 months of therapy. Sore throat and fever may be the earliest symptoms, so patients should be instructed to report these immediately, and repeated blood counts should be done. If agranulocytosis occurs, the drug should be discontinued, and treatment with granulocyte-colony stimulating factor may accelerate recovery.</li>
                        <li><strong>Hypothyroidism</strong> due to excessive dosing</li>
                        <li>Other adverse effects include rash, nausea, arthralgia, headache, dizziness, and parasthesia.</li>
                    </ul>
                    
                    <h4>Thionamides in Pregnancy & Lactation</h4>
                    <p>If a pregnant woman has hyperthyroidism, she should be treated with the smallest possible amount of these drugs because they cross the placenta; overtreatment causes fetal goiter.</p>
                    <p><strong>Propylthiouracil (PTU)</strong> should be used in the first trimester of pregnancy because of the risk of <strong>methimazole (MMI) embryopathy</strong>. Consideration should be given to discontinuing <strong>PTU</strong> after the first trimester and switching to <strong>MMI</strong> in order to decrease the incidence of liver disease.</p>
                    <p>Because of the potential for worse malformations with <strong>MMI</strong>, <strong>PTU</strong> tends to be the first choice in this class of drugs. However, <strong>PTU</strong> confers a higher risk of maternal agranulocytosis and liver failure.</p>


                    <ul>
                        <li>Surgery in the second trimester may be preferred to continued drug therapy.</li>
                        <li>They are safe in lactating women, but because of the risk of hepatotoxicity, <strong>carbimazole</strong> is preferred.</li>
                    </ul>
                    
                </div>
              </section>

              <section id='heading-4-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-2'>Radioactive Iodine (131I)</a>
                  </h3>
                </header>
                <div class='body'>
                    <h4></h4>
                    <p>Is the first-line treatment particularly in the USA. It is concentrated in the thyroid gland. Destruction of thyroid tissue is produced primarily by emission of beta particles. Since beta particles have a very limited ability to penetrate any type of physical barrier, these particles do not travel outside the thyroid, so damage to surrounding tissue is minimal. Reduction of thyroid function is gradual. Initial effects become apparent in days or weeks, and full effects develop in 2-3 months.</p>
                    
                    <h4>Uses</h4>
                    <p>Is usually given for middle-aged and elderly patients:</p>
                    <ol>
                        <li>In Grave's disease</li>
                        <li>In thyroid cancer - high doses are required</li>
                        <li>For the diagnosis of a variety of thyroid disorders</li>
                    </ol>
                    
                    <h4>Advantages</h4>
                    <ul>
                        <li>Easy administration (orally in solution as sodium 131I, given as one single dose)</li>
                        <li>Low cost</li>
                        <li>Patients are spared the risks, discomfort, and expense of thyroid surgery</li>
                        <li>Death due to 131I has never occurred</li>
                        <li>No tissue other than the thyroid is injured</li>
                    </ul>
                    
                    <h4>Disadvantages</h4>
                    <ul>
                        <li>Delayed effect (for 1-2 months)</li>
                        <li>Delayed hypothyroidism</li>
                        <li>The theoretical risk of thyroid cancer</li>
                    </ul>
                    
                    <h4>Contraindications</h4>
                    <ol>
                        <li>Children - risk of delayed hypothyroidism is higher than in adults</li>
                        <li>Pregnancy - after the first trimester, it may damage:
                            <ul>
                                <li>the immature thyroid</li>
                                <li>it causes generalized developmental harm during the whole pregnancy</li>
                            </ul>
                        </li>
                        <li>Breastfeeding</li>
                    </ol>
                    
                </div>
              </section>

              <section id='heading-4-3'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-3'>Iodide Products (Nonradioactive)</a>
                  </h3>
                </header>
                <div class='body'>
                    <h4></h4>
                    <ol>
                        <li>Strong iodine solution (<strong>Lugol's solution</strong>)</li>
                        <li>Sodium iodide</li>
                        <li>Potassium iodide</li>
                    </ol>
                    <p>All have the same mechanism of action and similar pharmacological effects.</p>

                                        
                    <h4>Lugol's Solution</h4>
                    <p>Is a mixture of elemental iodine and potassium iodide. It suppresses thyroid function by:</p>
                    <ol>
                        <li>Decreasing iodine uptake, suppressing both the iodination of tyrosine and coupling of iodinated tyrosine</li>
                        <li>Inhibiting release of thyroid hormone into the bloodstream</li>
                    </ol>
                    <p>With long-term iodide administration, suppressant effects become weaker, so iodide is rarely used alone to produce thyroid suppression.</p>
                    
                    <ul>
                        <li><strong>Therapeutic uses:</strong>
                            <ol>
                                <li>In preparation for surgery</li>
                                <li>Thyrotoxic crisis</li>
                                <li>As antiseptic</li>
                                <li>As expectorant</li>
                                <li>As contrast media in radiology</li>
                            </ol>
                        </li>
                        <li><strong>Adverse effects:</strong>
                            <p>Chronic ingestion of iodine causes <em>iodism</em> characterized by:</p>
                            <ul>
                                <li>Metallic taste</li>
                                <li>Burning sensation in mouth & throat</li>
                                <li>Soreness of teeth & gums</li>
                                <li>Frontal headache</li>
                                <li>Coryza (nasal inflammation & sneezing)</li>
                                <li>Various skin eruptions</li>
                                <li>Excessive salivation with painful salivary gland</li>
                            </ul>
                        </li>
                        <li><strong>Overdose:</strong>
                            <p>Iodine is corrosive, and overdose will injure the GIT, causing abdominal pain, vomiting, & diarrhea.</p>
                        </li>
                    </ul>
                    
                </div>
              </section>

              <section id='heading-4-4'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-4'>Beta Blockers</a>
                  </h3>
                </header>
                <div class='body'>
                    <p>Œ≤-blockers without intrinsic sympathomimetic effect (ISA) like propranolol, cause clinical improvement of hyperthyroid symptoms but do not alter thyroid hormone levels, so they are not used as sole therapy.</p>
                    
                    <h4>Uses</h4>
                    <ol>
                        <li>In patients on a long wait for the effect of antithyroid drugs</li>
                        <li>In preparation for surgery</li>
                        <li>As a part of treatment of acute hyperthyroid crisis</li>
                    </ol>
                    
    
                </div>
              </section>
        </div>
      </section>








      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1" class="comment-button">
            here
            <img src="../images/icons/whatsapp.png" alt="Image Icon">
          </a>
        </div>

        <div class="contributors-container">

          <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div>
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiüëã</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
